DHI
35
6
CPB
34
2
ORCL
62
2
CAG
36
2
DE
53
-3
ORLY
50
3
GE
64
-6
MAT
49
3
PH
69
5
PHM
49
3
AN
52
3
PRU
47
2
RL
75
5
PEP
27
-11
AA
54
6
RF
70
3
AMP
50
4
NWS
74
4
HRB
49
3
NOV
34
-3
DHI
35
6
CPB
34
2
ORCL
62
2
CAG
36
2
DE
53
-3
ORLY
50
3
GE
64
-6
MAT
49
3
PH
69
5
PHM
49
3
AN
52
3
PRU
47
2
RL
75
5
PEP
27
-11
AA
54
6
RF
70
3
AMP
50
4
NWS
74
4
HRB
49
3
NOV
34
-3
Financhill
Back

AAC Technologies Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
66

AACAY
AAC Technologies Holdings

Last Price:
$4.84
Seasonality Move:
-3.34%
Buy
65

HALO
Halozyme Therapeutics

Last Price:
$53.50
Seasonality Move:
5.34%
Buy
66
AAC Technologies Holdings (AACAY) is a Buy

Is AAC Technologies Holdings a Buy, Sell or Hold?

  • The current AAC Technologies Holdings [AACAY] share price is $4.84. The Score for AACAY is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AACAY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $52.80. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AACAY Stock Price Chart

What is AAC Technologies Holdings's stock price today?

  • The AAC Technologies Holdings share price today is $4.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AACAY is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $52.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AACAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 48.94 Sell
Chaikin Money Flow: -1113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.7 - 4.98) Buy
Bollinger Bands (100): (4.56 - 6.06) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 41.17 Sell
Chaikin Money Flow: 1656587 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.04 - 54.76) Sell
Bollinger Bands (100): (54.19 - 62.43) Sell

AACAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.93 Sell
20-day SMA: 4.83 Buy
50-day SMA: 4.75 Buy
200-day SMA: 4.79 Buy
8-day EMA: 4.91 Sell
20-day EMA: 4.88 Sell
50-day EMA: 4.93 Sell
200-day EMA: 4.72 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.52 Sell
20-day SMA: 54.06 Sell
50-day SMA: 56.82 Sell
200-day SMA: 55.9 Sell
8-day EMA: 53.36 Sell
20-day EMA: 54.15 Sell
50-day EMA: 55.95 Sell
200-day EMA: 55.1 Sell

AAC Technologies Holdings Earnings Growth & AACAY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

AAC Technologies Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):